Literature DB >> 12960126

Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma.

Gunhild M Maelandsmo1, Ruth Holm, Jahn M Nesland, Øystein Fodstad, Vivi Ann Flørenes.   

Abstract

PURPOSE: The purpose of the present work was to analyze the expression of beta-catenin in a panel of superficial and nodular spreading primary and metastatic melanomas, and to correlate the level of immunohistochemical staining to clinicopathological parameters. EXPERIMENTAL
DESIGN: Expression of beta-catenin was examined by immunohistochemistry in 106 superficial and 58 nodular spreading primary melanomas, as well as in 66 metastatic lesions.
RESULTS: Membrane-associated staining was detected in nearly all of the cases, and no association to clinical parameters could be revealed. When cytoplasmic localization of the protein was recorded, a significant higher fraction of the superficial than the nodular spreading primary lesions expressed the protein in the majority of the cells (P < 0.0001). Interestingly, metastatic lesions from superficial melanomas demonstrated down-regulated expression of the protein, and in agreement with this a significant inverse correlation between protein expression and the vertical thickness of the primary lesion was detected (P = 0.012). Furthermore, a significant correlation between cytoplasmic localization and disease-free survival (P = 0.0006) was revealed, but beta-catenin did not have any significant impact on overall survival for this group of patients (P = 0.0824). No association was detected between beta-catenin expression and clinicopathological parameters in the nodular subgroup of melanomas, indicating that the protein may play different roles in the malignant progression of the two main types of melanomas.
CONCLUSION: In summary, we hypothesize that cytoplasmic beta-catenin has a protective role in early melanoma development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12960126

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  44 in total

1.  Chemical-genetic screen identifies riluzole as an enhancer of Wnt/β-catenin signaling in melanoma.

Authors:  Travis L Biechele; Nathan D Camp; Daniel M Fass; Rima M Kulikauskas; Nick C Robin; Bryan D White; Corinne M Taraska; Erin C Moore; Jeanot Muster; Rakesh Karmacharya; Stephen J Haggarty; Andy J Chien; Randall T Moon
Journal:  Chem Biol       Date:  2010-11-24

2.  Melanoma prognostic model using tissue microarrays and genetic algorithms.

Authors:  Bonnie E Gould Rothberg; Aaron J Berger; Annette M Molinaro; Antonio Subtil; Michael O Krauthammer; Robert L Camp; William R Bradley; Stephan Ariyan; Harriet M Kluger; David L Rimm
Journal:  J Clin Oncol       Date:  2009-11-02       Impact factor: 44.544

Review 3.  Wnt signaling in skin development, homeostasis, and disease.

Authors:  Xinhong Lim; Roel Nusse
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-02-01       Impact factor: 10.005

Review 4.  Targeting Wnt pathways in disease.

Authors:  Zachary F Zimmerman; Randall T Moon; Andy J Chien
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-11-01       Impact factor: 10.005

5.  Tspan8-β-catenin positive feedback loop promotes melanoma invasion.

Authors:  Manale El Kharbili; Gweltaz Agaësse; Laetitia Barbollat-Boutrand; Roxane M Pommier; Arnaud de la Fouchardière; Lionel Larue; Julie Caramel; Alain Puisieux; Odile Berthier-Vergnes; Ingrid Masse
Journal:  Oncogene       Date:  2019-01-24       Impact factor: 9.867

Review 6.  Can we safely target the WNT pathway?

Authors:  Michael Kahn
Journal:  Nat Rev Drug Discov       Date:  2014-07       Impact factor: 84.694

7.  Increased levels of β-catenin, LEF-1, and HPA-1 correlate with poor prognosis for acral melanoma with negative BRAF and NRAS mutation in BRAF exons 11 and 15 and NRAS exons 1 and 2.

Authors:  Sanxiong Xu; Zuozhang Yang; Jinyu Zhang; Yongxin Jiang; Yongbin Chen; Hongjun Li; Xuefeng Liu; Da Xu; Yanjin Chen; Yihao Yang; Ya Zhang; Dongxu Li; Junfeng Xia
Journal:  DNA Cell Biol       Date:  2015-01       Impact factor: 3.311

Review 8.  A Wnt survival guide: from flies to human disease.

Authors:  Andy J Chien; William H Conrad; Randall T Moon
Journal:  J Invest Dermatol       Date:  2009-01-29       Impact factor: 8.551

9.  Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model.

Authors:  Andy J Chien; Erin C Moore; Anke S Lonsdorf; Rima M Kulikauskas; Bonnie Gould Rothberg; Aaron J Berger; Michael B Major; Sam T Hwang; David L Rimm; Randall T Moon
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-14       Impact factor: 11.205

Review 10.  A re-evaluation of the "oncogenic" nature of Wnt/beta-catenin signaling in melanoma and other cancers.

Authors:  Olivia M Lucero; David W Dawson; Randall T Moon; Andy J Chien
Journal:  Curr Oncol Rep       Date:  2010-09       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.